Literature DB >> 8755579

Diazepam binding inhibitor is a potent cholecystokinin-releasing peptide in the intestine.

K H Herzig1, I Schön, K Tatemoto, Y Ohe, Y Li, U R Fölsch, C Owyang.   

Abstract

Pancreatic proteases in the duodenum inhibit the release of cholecystokinin (CCK) and thus exert feedback control of pancreatic exocrine secretion. Exclusion of proteases from the duodenum either by the diversion of bile-pancreatic juice or by the addition of protease inhibitors stimulates exocrine pancreatic secretion. The mechanism by which pancreatic proteases in the duodenum regulate CCK secretion is unknown. In this study, we isolated a trypsin-sensitive peptide that is secreted intraduodenally, releases CCK, and stimulates pancreatic enzyme secretion in rats. This peptide was found to be identical to the porcine diazepam binding inhibitor by peptide sequencing and mass spectrometry analysis. Intraduodenal infusion of 200 ng of synthetic porcine diazepam binding inhibitor1-86 in rats significantly stimulated pancreatic amylase output. Infusion of the CCK antagonist MK-329 completely blocked the diazepam binding inhibitor-stimulated amylase secretion. Similarly, diazepam binding inhibitor33-52 [corrected] also stimulated CCK release and pancreatic secretion in a dose-dependent manner although it was 100 times less potent than the whole peptide. Using a perfusion system containing isolated mucosal cells from the proximal intestine of rats, porcine diazepam binding inhibitor 10(-12) M) dose dependently stimulated CCK secretion. In separate studies, it was demonstrated that luminal secretion of the diazepam binding inhibitor immunoreactivity (7.5 X 10(11) M) could be detected in rat's intestinal washing following the diversion of bile-pancreatic juice. The secretion of this peptide was inhibited by atropine. In conclusion, we have isolated and characterized a CCK-releasing peptide that has a sequence identical to the porcine diazepam binding inhibitor from pig intestinal mucosa and that stimulates CCK release when administered intraduodenally in rat. This peptide may mediate feedback regulation of pancreatic enzyme secretion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8755579      PMCID: PMC38851          DOI: 10.1073/pnas.93.15.7927

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

Review 1.  Diazepam binding inhibitor (DBI): a peptide with multiple biological actions.

Authors:  E Costa; A Guidotti
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

2.  Evaluation of a new alpha-amylase assay using 4.6-ethylidene-(G7)-1-4-nitrophenyl-(G1)-alpha-D-maltoheptaoside as substrate.

Authors:  J D Kruse-Jarres; C Kaiser; J C Hafkenscheid; W Hohenwallner; W Stein; J Bohner; G Klein; W Poppe; E Rauscher
Journal:  J Clin Chem Clin Biochem       Date:  1989-02

3.  A cholecystokinin releasing peptide mediates feedback regulation of pancreatic secretion.

Authors:  L Lu; D Louie; C Owyang
Journal:  Am J Physiol       Date:  1989-02

4.  Mechanism of acid-induced release of secretin in rats. Presence of a secretin-releasing peptide.

Authors:  P Li; K Y Lee; T M Chang; W Y Chey
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

5.  Immunohistochemical localization of porcine diazepam-binding inhibitor (DBI) to rat endocrine pancreas.

Authors:  O Johansson; M Hilliges; C G Ostenson; E Sandberg; S Efendic; V Mutt
Journal:  Cell Tissue Res       Date:  1991-02       Impact factor: 5.249

6.  Effects of porcine diazepam-binding inhibitor on insulin and glucagon secretion in vitro from the rat endocrine pancreas.

Authors:  C G Ostenson; B Ahrén; S Karlsson; E Sandberg; S Efendic
Journal:  Regul Pept       Date:  1990-07-30

7.  Acyl-CoA-binding protein in the rat. Purification, binding characteristics, tissue concentrations and amino acid sequence.

Authors:  J Knudsen; P Højrup; H O Hansen; H F Hansen; P Roepstorff
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

8.  Independent release of peptide YY (PYY) into the circulation and ileal lumen of the awake dog.

Authors:  D W McFadden; M Rudnicki; M S Nussbaum; A Balasubramaniam; J E Fischer
Journal:  J Surg Res       Date:  1989-04       Impact factor: 2.192

9.  Isolation and characterization of porcine diazepam-binding inhibitor, a polypeptide not only of cerebral occurrence but also common in intestinal tissues and with effects on regulation of insulin release.

Authors:  Z W Chen; B Agerberth; K Gell; M Andersson; V Mutt; C G Ostenson; S Efendić; J Barros-Söderling; B Persson; H Jörnvall
Journal:  Eur J Biochem       Date:  1988-06-01

10.  Feedback regulation by trypsin: evidence for intraluminal CCK-releasing peptide.

Authors:  K Miyasaka; D F Guan; R A Liddle; G M Green
Journal:  Am J Physiol       Date:  1989-08
View more
  9 in total

1.  Amino acids stimulate cholecystokinin release through the Ca2+-sensing receptor.

Authors:  Yu Wang; Rashmi Chandra; Leigh Ann Samsa; Barry Gooch; Brian E Fee; J Michael Cook; Steven R Vigna; Augustus O Grant; Rodger A Liddle
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-12-23       Impact factor: 4.052

2.  Diazepam-binding inhibitor mediates feedback regulation of pancreatic secretion and postprandial release of cholecystokinin.

Authors:  Y Li; Y Hao; C Owyang
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

3.  Bombesin stimulates cholecystokinin secretion through mitogen-activated protein-kinase-dependent and -independent mechanisms in the enteroendocrine STC-1 cell line.

Authors:  E Némoz-Gaillard; M Cordier-Bussat; C Filloux; J C Cuber; E Van Obberghen; J A Chayvialle; J Abello
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

4.  Cefaclor, a cephalosporin antibiotic, delays gastric emptying rate by a CCK-A receptor-mediated mechanism in the rat.

Authors:  A Bozkurt; M Deniz; B C Yegen
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

5.  Role of prostaglandins in regulation of pancreatic enzyme secretion by various diets.

Authors:  B Holler; Y Ogami; A Zabel-Langhennig; D Tillack; K Engeland; V Keim; J Mössner
Journal:  Dig Dis Sci       Date:  2001-02       Impact factor: 3.199

6.  Expression of functional GABAA receptors in cholecystokinin-secreting gut neuroendocrine murine STC-1 cells.

Authors:  G Glassmeier; K H Herzig; M Höpfner; K Lemmer; A Jansen; H Scherubl
Journal:  J Physiol       Date:  1998-08-01       Impact factor: 5.182

Review 7.  From benzodiazepines to fatty acids and beyond: revisiting the role of ACBP/DBI.

Authors:  Thierry Alquier; Catherine A Christian-Hinman; Julieta Alfonso; Nils J Færgeman
Journal:  Trends Endocrinol Metab       Date:  2021-09-23       Impact factor: 12.015

8.  Role of Cholecystectomy in Symptomatic Hyperkinetic Gallbladder Patients.

Authors:  Jai P Singh
Journal:  Case Rep Surg       Date:  2021-03-25

9.  Release of Cholecystokinin from Rat Intestinal Mucosal Cells and the Enteroendocrine Cell Line STC-1 in Response to Maleic and Succinic Acid, Fermentation Products of Alcoholic Beverages.

Authors:  Jan-Hendrik Egberts; Ghulam Shere Raza; Cornelia Wilgus; Stefan Teyssen; Karlheinz Kiehne; Karl-Heinz Herzig
Journal:  Int J Mol Sci       Date:  2020-01-16       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.